Sanofi sees renewed growth

Sanofi SA is forecasting a rise in adjusted earnings per share in 2018 of between 2% and 5% as new products gradually overtake the decline in sales of its core diabetes franchise.

Full text available to subscribers only. Click here for information on subscribing to MedNous.